Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04663464 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.
A Phase 1 study, sponsored by Radius Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT04663464 is a Phase 1 study that has completed, run by Radius Health. The registered enrollment target is 52 participants.
The verdict
NCT04663464, a Phase 1 study, has completed, sponsored by Radius Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
A study to evaluate and compare the PK profiles of abaloparatide-SC 80 μg and abaloparatide-sMTS 300 μg in a cohort of healthy men and to make a similar evaluation in a cohort of healthy women
Interventions
- COMBINATION_PRODUCT abaloparatide-sMTS
- COMBINATION_PRODUCT abaloparatide-SC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-11-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04663464
The ClinicalTrials.gov registry entry for NCT04663464 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radius Health, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which abaloparatide-sMTS is the first listed.
NCT04663464 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04663464 about?
NCT04663464 is a clinical study titled "Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.". A study to evaluate and compare the PK profiles of abaloparatide-SC 80 μg and abaloparatide-sMTS 300 μg in a cohort of healthy men and to make a similar evaluation in a cohort of healthy women
What is the current status of trial NCT04663464?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2020-11-16. Estimated completion is 2021-11-19.
What interventions are being tested in trial NCT04663464?
The interventions under investigation include: abaloparatide-sMTS (COMBINATION_PRODUCT), abaloparatide-SC (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04663464?
This trial is sponsored by Radius Health, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.